Publicacions en què col·labora amb José Alejandro Pérez Fidalgo (3)

2018

  1. Balixafortide (a novel CXCR4 inhibitor) and eribulin in HER2-neg metastatic breast cancer (MBC) patients (pts): A phase I trial

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii91-viii92

2016

  1. Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature

    Critical Reviews in Oncology/Hematology, Vol. 97, pp. 96-106

2014

  1. Subcutaneous trastuzumab:Drug development and current position

    Clinical and Translational Oncology, Vol. 16, Núm. 10, pp. 859-864